SCHEMBL3136575

SCHEMBL3136575

CCN1C(=O)SC(=Cc2ccc(-c3ccccc3Cl)o2)C1=S

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
INSR P06213 1/20 0.59
IGF1R P08069 1/20 0.59
MAP3K5 Q99683 4/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
ALDH1A1 P00352 2/20 0.58
MAPT P10636 2/20 0.58
LMNA P02545 2/20 0.58
POLB P06746 2/20 0.58
HTT P42858 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
HPGD P15428 1/20 0.58
MAPK1 P28482 1/20 0.58
RECQL P46063 1/20 0.58
MCL1 Q07820 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
GSK3A P49840 2/20 0.55
GSK3B P49841 2/20 0.55
PIK3CG P48736 1/20 0.55
TNFRSF1A P19438 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3136571 1.00 INSR (0.59) INSRIGF1RMAP3K5MEN1KMT2A
SCHEMBL3136564 1.00 INSR (0.59) INSRIGF1RMAP3K5MEN1KMT2A
SCHEMBL3135824 0.88 PIK3CA (0.56) MAP3K5MEN1KMT2APOLBPIK3CG
SCHEMBL3135820 0.88 PIK3CA (0.56) MAP3K5MEN1KMT2APOLBPIK3CG
SCHEMBL3135831 0.88 PIK3CA (0.56) MAP3K5MEN1KMT2APOLBPIK3CG
SCHEMBL3136535 0.87 TNFRSF1A (0.53) INSRIGF1RMAP3K5MEN1KMT2A
SCHEMBL3136530 0.87 TNFRSF1A (0.53) INSRIGF1RMAP3K5MEN1KMT2A
SCHEMBL3136522 0.87 TNFRSF1A (0.53) INSRIGF1RMAP3K5MEN1KMT2A
SCHEMBL3129316 0.87 MAP3K5 (0.58) INSRIGF1RMAP3K5MEN1KMT2A
SCHEMBL3129314 0.87 MAP3K5 (0.58) INSRIGF1RMAP3K5MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-30 US claimed
WO-2010044924-A1 NOVEL ANTIVIRAL AGENTS FOR ENVELOPED VIRUSES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-04-22 WO claimed
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses MAVS, LAMP1, HAVCR2 INSR 3037/4885IGF1R 3107/4885MAP3K5 3869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.